CoChat

Vector Design Tour de Force: Integrating Combinatorial and Rational Approaches to Derive Novel Adeno-associated Virus Variants

Open access
Marsic, Damien, Govindasamy, Lakshmanan, Currlin, Seth, Markusic, David M, Tseng, Yu-Shan, Herzog, Roland W, Agbandje-McKenna, Mavis, Zolotukhin, Sergei · 2014 · Molecular Therapy
Cited by 72

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Abstract

Methodologies to improve existing adeno-associated virus (AAV) vectors for gene therapy include either rational approaches or directed evolution to derive capsid variants characterized by superior transduction efficiencies in targeted tissues. Here, we integrated both approaches in one unified design strategy of "virtual family shuffling" to derive a combinatorial capsid library whereby only variable regions on the surface of the capsid are modified. Individual sublibraries were first assembled in order to preselect compatible amino acid residues within restricted surface-exposed regions to minimize the generation of dead-end variants. Subsequently, the successful families were interbred to derive a combined library of ~8 × 10(5) complexity. Next-generation sequencing of the packaged viral DNA revealed capsid surface areas susceptible to directed evolution, thus providing guidance for future designs. We demonstrated the utility of the library by deriving an AAV2-based vector characterized by a 20-fold higher transduction efficiency in murine liver, now equivalent to that of AAV8.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/mt.2014.139

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 18 references

Research works printed but not linked: 24

  1. Wu, 2000, Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism, J Virol, 74, 8635, 10.1128/JVI.74.18.8635-8647.2000 · DOI · Paper page
  2. Aslanidi, 2012, High-efficiency transduction of human monocyte-derived dendritic cells by capsid-modified recombinant AAV2 vectors, Vaccine, 30, 3908, 10.1016/j.vaccine.2012.03.079 · DOI · Paper page
  3. Aslanidi, 2013, Optimization of the capsid of recombinant adeno-associated virus 2 (AAV2) vectors: the final threshold?, PLoS One, 8, e59142, 10.1371/journal.pone.0059142 · DOI · Paper page
  4. Müller, 2003, Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors, Nat Biotechnol, 21, 1040, 10.1038/nbt856 · DOI · Paper page
  5. Yang, 2009, A myocardium tropic adeno-associated virus (AAV) evolved by DNA shuffling and in vivo selection, Proc Natl Acad Sci USA, 106, 3946, 10.1073/pnas.0813207106 · DOI · Paper page
  6. DiPrimio, 2008, Surface loop dynamics in adeno-associated virus capsid assembly, J Virol, 82, 5178, 10.1128/JVI.02721-07 · DOI · Paper page
  7. Opie, 2003, Identification of amino acid residues in the capsid proteins of adeno-associated virus type 2 that contribute to heparan sulfate proteoglycan binding, J Virol, 77, 6995, 10.1128/JVI.77.12.6995-7006.2003 · DOI · Paper page
  8. Summerford, 1998, Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions, J Virol, 72, 1438, 10.1128/JVI.72.2.1438-1445.1998 · DOI · Paper page
  9. Shannon, 1997, The mathematical theory of communication. 1963, MD Comput, 14, 306
  10. Sands, 2011, AAV-mediated liver-directed gene therapy, Methods Mol Biol, 807, 141, 10.1007/978-1-61779-370-7_6 · DOI · Paper page
  11. Gao, 2002, Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy, Proc Natl Acad Sci USA, 99, 11854, 10.1073/pnas.182412299 · DOI · Paper page
  12. Nakai, 2005, Unrestricted hepatocyte transduction with adeno-associated virus serotype 8 vectors in mice, J Virol, 79, 214, 10.1128/JVI.79.1.214-224.2005 · DOI · Paper page
  13. Hurlbut, 2010, Preexisting immunity and low expression in primates highlight translational challenges for liver-directed AAV8-mediated gene therapy, Mol Ther, 18, 1983, 10.1038/mt.2010.175 · DOI · Paper page
  14. Pulicherla, 2011, Engineering liver-detargeted AAV9 vectors for cardiac and musculoskeletal gene transfer, Mol Ther, 19, 1070, 10.1038/mt.2011.22 · DOI · Paper page
  15. Ng, 2010, Structural characterization of the dual glycan binding adeno-associated virus serotype 6, J Virol, 84, 12945, 10.1128/JVI.01235-10 · DOI · Paper page
  16. Coco, 2002, Growth factor engineering by degenerate homoduplex gene family recombination, Nat Biotechnol, 20, 1246, 10.1038/nbt757 · doi:10.1038/nbt757
  17. Cost, 2007, Directed assembly of DNA molecules via simultaneous ligation and digestion, Biotechniques, 42, 84, 10.2144/000112283 · doi:10.2144/000112283
  18. Samulski, 1987, A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication, J Virol, 61, 3096, 10.1128/JVI.61.10.3096-3101.1987 · DOI · Paper page
  19. Gibson, 2009, Enzymatic assembly of DNA molecules up to several hundred kilobases, Nat Methods, 6, 343, 10.1038/nmeth.1318 · DOI · Paper page
  20. Zolotukhin, 1999, Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield, Gene Ther, 6, 973, 10.1038/sj.gt.3300938 · DOI · Paper page
  21. Arad, 1998, Modified Hirt procedure for rapid purification of extrachromosomal DNA from mammalian cells, Biotechniques, 24, 760, 10.2144/98245bm14 · DOI · Paper page
  22. Li, 1997, Role for highly regulated rep gene expression in adeno-associated virus vector production, J Virol, 71, 5236, 10.1128/JVI.71.7.5236-5243.1997 · DOI · Paper page
  23. Yang, 2008, Development of optimal bicistronic lentiviral vectors facilitates high-level TCR gene expression and robust tumor cell recognition, Gene Ther, 15, 1411, 10.1038/gt.2008.90 · DOI · Paper page
  24. Sharma, 2012, 2A peptides provide distinct solutions to driving stop-carry on translational recoding, Nucleic Acids Res, 40, 3143, 10.1093/nar/gkr1176 · DOI

Cited by

See all 72

Metadata

Authors
Marsic, D., Govindasamy, L., Currlin, S., Markusic, D. M., Tseng, Y.-S., Herzog, R. W., Agbandje-McKenna, M., & Zolotukhin, S.
Venue
Molecular Therapy
Publisher
Elsevier BV
Published
2014-11
Volume
22
Issue
11
Pages
1900-1909
ISSN
1525-0016 (ISSN-L)
OpenAlex
W2086174979
Cited by
72
References
18
FWCI
3.17
Type
journal article
Language
en
Open access
hybrid
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Vector Design Tour de Force: Integrating Combinatorial and Rational Approaches to Derive Novel Adeno-associated Virus Variants. https://app.cochat.ai/papers/10.1038/mt.2014.139
The paper
Marsic, D., Govindasamy, L., Currlin, S., Markusic, D. M., Tseng, Y.-S., Herzog, R. W., Agbandje-McKenna, M., & Zolotukhin, S. (2014). Vector Design Tour de Force: Integrating Combinatorial and Rational Approaches to Derive Novel Adeno-associated Virus Variants. Molecular Therapy. https://doi.org/10.1038/mt.2014.139

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.